insights_auto
Why is AVTX down 6.92%?
Dive Deeperchevron_right
AVTX:NASDAQ
Avalo Therapeutics Inc
$13.59
arrow_downward
-6.92%(-1.01) 1D
$13.59
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 6, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AVTX...
Open
$14.58
High
$14.58
Low
$13.23
Mkt. cap
748.30M
Avg. vol.
1.07M
Volume
955.55K
52-wk high
$24.27
52-wk low
$12.51
EPS
-$4.75
Beta
0.68
Shares outstanding
53.63M
No. of employees
33
Open
$14.58
High
$14.58
Low
$13.23
Mkt. cap
748.30M
Avg. vol.
1.07M
Volume
955.55K
52-wk high
$24.27
52-wk low
$12.51
EPS
-$4.75
Beta
0.68
Shares outstanding
53.63M
No. of employees
33
News stories
From web sources and news partners
Simply Wall Street
·
45 minutes ago
What Does Ascendis Pharma (ASND) Gain From Its CNP Patent Settlement?
TheStreet Pro
·
30 minutes ago
Continued Broadening Lifts S&P 500 to First Record Since August
Stocktwits
·
3 hours ago
S&P 500 And Nasdaq 100 Soar To Record Highs Amid Rising Bets Of Strong Quarterly Earnings — CEG, LCID, SPCX, MRVL In Focus
Deadline
·
2 hours ago
Skydance Shares Fall In New York Stock Exchange Debut Amid Debt Debate
About Avalo Therapeutics Inc
CEO-
Employees33
Founded2011
HeadquartersRockville, Pennsylvania, United States
SectorBiotechnology
Websiteavalotx.com